No Data
BofA Securities Initiates Haemonetics(HAE.US) With Hold Rating, Announces Target Price $85
BofA Securities analyst Craig Bijou initiates coverage on $Haemonetics(HAE.US)$ with a hold rating, and sets the target price at $85.According to TipRanks data, the analyst has a success rate of 42.9%
Haemonetics Price Target Announced at $85.00/Share by B of A Securities
BTIG Initiates Haemonetics(HAE.US) With Buy Rating, Announces Target Price $112
BTIG analyst Marie Thibault initiates coverage on $Haemonetics(HAE.US)$ with a buy rating, and sets the target price at $112.According to TipRanks data, the analyst has a success rate of 33.6% and a
Express News | Haemonetics Corp : Btig Initiates Coverage With Buy Rating; Price Target $112
Haemonetics: A Solid Investment in MedTech With Promising Growth and Valuation Upside
Haemonetics (NYSE:HAE) Shareholders Have Endured a 38% Loss From Investing in the Stock Five Years Ago